Podiatry Associates Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 8901 W 74th St, Suite 200, Shawnee Mission, KS 66204 Phone: 913-432-5052 Fax: 913-432-9990 |
Todd Martin Vanwyngarden, D.P.M. Podiatrist - Foot Surgery Medicare: Accepting Medicare Assignments Practice Location: 8901 W 74th St, Suite 200, Shawnee Mission, KS 66204 Phone: 913-432-5052 Fax: 913-432-9990 |
Michael Jay Nachlas, D.P.M. Podiatrist - Foot Surgery Medicare: Medicare Enrolled Practice Location: 8901 W 74th St, Suite 200, Shawnee Mission, KS 66204 Phone: 913-432-5052 Fax: 913-432-9990 |
Mitchell F Dorris, D.P.M. Podiatrist - Foot Surgery Medicare: Accepting Medicare Assignments Practice Location: 8901 W 74th St, Suite 200, Shawnee Mission, KS 66204 Phone: 913-432-5052 Fax: 913-432-9990 |
News Archive
Peregrine Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing innovative monoclonal antibodies for the treatment of cancer and viral infections, will present data from three Phase II clinical trials highlighting the clinical potential of its unique phosphatidylserine -targeting antibody bavituximab for the treatment of solid tumors.
The Critical Path Institute's (C-Path) Critical Path for Alzheimer's Disease (CPAD) Consortium today announced its participation as a Partner with the Alzheimer's Disease Data Initiative (ADDI), a 501(c)(3) medical research organization which launched today.
In a New York Times opinion piece, columnist Nicholas Kristof examines a new plan to tackle obstetric fistula, "a childbirth injury, often suffered by a teenager in Africa or Asia whose pelvis is not fully grown." According to Kristof, "Just about the happiest thing that can happen to such a woman is an encounter with Dr. Lewis Wall, an ob-gyn at Washington University in St. Louis.
For nearly two decades, the medical world and the American public have grappled with the lightning-rod topic of stem cells, in particular the controversy surrounding cells from human embryos. But when researchers four years ago successfully "reprogrammed" adult body cells to become stem cells, some thought the ethical debate was nearly over. Those redirected cells, known as induced pluripotent cells, or iPS cells, show potential as therapy.
The World Health Organization and the Foundation for Innovative New Diagnostics announced today that a memorandum of understanding has been signed by the two organizations to formalize a strategic collaboration that will strengthen diagnosis in resource-poor countries by closing major diagnostic gaps at country level and bolstering disease surveillance that will inform public health initiatives and enhance outbreak preparedness and response.
› Verified 7 days ago